Hyperopia
Visual, refractive outcomes positive at 9 months with Teneo excimer laser for myopia
Patients with myopia and myopic astigmatism who underwent LASIK with the Bausch + Lomb Technolas Teneo 317 model 2 excimer laser experienced positive visual and refractive outcomes and a high level of satisfaction, according to a study.
VIDEO: Toric IOL performs well in hyperopic anisometropia, high astigmatism
FRANKFURT, Germany — In this Healio Video Perspective from the ESCRS winter meeting, Magda Rau, MD, speaks about the implantation of customized asymmetric multifocal toric IOLs in patients with hyperopic anisometropia and high astigmatism.
Cross-linking shows efficacy in recurrent corneal erosion syndrome
FRANKFURT, Germany — Corneal cross-linking proved to be an effective alternative treatment for recurrent corneal erosion syndrome and offered relief from symptoms without recurrence at 1 year.
VIDEO: Surgeon presents long-term outcomes of presbyopic phakic lens
FRANKFURT, Germany — In this Healio Video Perspective from the ESCRS winter meeting, Pavel Stodulka, MD, PhD, speaks about his long-term data with the presbyopic phakic IPCL from Eyeol UK.
Small aperture IOL a reliable option for irregular corneas in the right candidates
WAILEA, Hawaii — The IC-8 Apthera IOL is a reliable option for managing irregular corneas, as long as the right candidates are selected, according to a presenter here at Hawaiian Eye 2024.
Axial length, corneal radius may predict myopia risk
Posterior vitreous depth developed differently in children who were high- vs. low-risk for myopia, while axial length/corneal radius most accurately identified overall myopia risk, according to recent research.
BLOG: Categorize prospective refractive lens exchange candidates
Many of us have noticed that refractive lens exchanges recently are a boom business. They have always been the only refractive solution for some patients, but increasingly sophisticated IOLs are turning more patients into candidates.
Piggyback IOL may be ideal for postoperative residual hyperopia
Our IOL power estimation is reasonably accurate, with most modern formulas being able to deliver about 80% of patients to within 0.5 D of the intended target.